They also estimated the probability of prostate cancer across age groups and found that it jumped from 2.63% (1 in 38) in men aged 40 to 59 years to 6.84% (1 in 15) in those aged 60 to 69 years and 12.54% (1 in 8) in those aged 70 years or older. Unfortunately, diagnosis in...
Las Vegas--Brachytherapy is a growing treatment choice for menwith low-risk prostate cancer, although it is still selected by less than22% of men with the disease, according to San Francisco researchers. Theuse of androgen ablation has also increased, the researchers found in ananalysis of data...
Learn how Myriad’s genetic testing can help you and your provider navigate crucial prostate cancer treatment decisions with personalized genetic insights.
but which of these risk factors cause a prostate cell to become cancerous is not fully known. For a cancer to develop, changes must occur in the chemicals that make up the DNA, which makes up the genes in the cell. The genes control how the cell ...
If you are diagnosed with early-stageprostate cancer, you usually have three treatment choices: monitoring (called active surveillance), surgery, or radiation therapy. Whole-gland ablation is an alternative to these treatments. Ablation uses strong cold or heat to burn or freeze prostate cancer. Pa...
cancer helps doctors understand the extent of the cancer and plan cancer treatment. Results of the treatment of similar Gleason score prostate cancer found at the same or similar stage can help the doctor and patient to make important decisions about choices of treatment to recommend or to accept...
Conclusions Specialist visits relate strongly to prostate cancer treatment choices. In light of these findings, prior evidence that specialists prefer the modality they themselves deliver and the lack of conclusive comparative studies demonstrating superiority of one modality over another, it is essential ...
Why do men choose one treatment over another? : A review of patient decision making for localized prostate cancer Treatment choices for localized prostate cancer appear to vary widely, although it is unclear whether this variation is a result of patient values or other... Steven,B.,Zeliadt,....
cancer helps doctors understand the extent of the cancer and plan cancer treatment. Results of the treatment of similar Gleason score prostate cancer found at the same or similar stage can help the doctor and patient to make important decisions about choices of treatment to recommend or to accept...
prostate cancer progression, which makes clinical trials in this area challenging. It’s clear that we need to expand our arsenal of treatment options for early-stage prostate cancer to provide patients with more choices that can effectively manage their disease while preserving their quality of ...